Stroke: The way things really are

Stroke

Volumn 25, Issue 6, 1994, Pages 1290-1294

  Scheinberg, Peritz ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Stroke management; Stroke prevention

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; DRUG EFFICACY; ENDARTERECTOMY; HIGH RISK POPULATION; HUMAN; MEDICAL DECISION MAKING; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; REVIEW; STROKE;

ANTICOAGULANTS; CEREBROVASCULAR DISORDERS; CLINICAL PROTOCOLS; ENDARTERECTOMY, CAROTID; HUMAN; PLATELET AGGREGATION INHIBITORS; RISK FACTORS;

EID: 0028235255     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.25.6.1290     Document Type: Article

References (55)

1. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53-59.
2. Antiplatelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J. 1988;296:320-331.
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
4. Antiplatelet Trialists Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J. 1994;308:81-106.
5. The SALT Collaborative. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemic events. Lancet. 1991;338:1345-1349.
6. UK-TIA Study Group. The United Kingdom transient ischemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044-1054.
7. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991;325: 1261-1266.
8. Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med. 1986;104:390-398.
9. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B, for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med. 1989;321:501-507.
10. Gent M, Blackely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panake E, Roberts RS, Sicurella J, Turpie AGG, and the CATS group. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1:1215-1220.
11. Balsano F, Rizzon P, Violi F, Scrutinio D, Cimminiello C, Aguglia F, Pasotti C, Rudelli G, and the Studio della Ticlopidina nell' Angina Instabile Group. Antiplatelet treatment with ticlopidine in unstable angina: a controlled multicenter clinical trial. Circulation. 1990;82:17-26.
12. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991; 84:527-539.
13. Albers GW, Sherman DG, Gress DR, Prulseth JE, Petersen P. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol. 1991;30:511-518.
14. Petersen P, Boysen G, Gotfredsen J, Andersen ED, Andersen B. Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet. 1989;1: 175-179.
15. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
16. Connolly SJ, Lanpacis A, Gent M, Roberts RS, Cairns JA, Joyner C, for the CAFA Study Coinvestigators. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18: 349-355.
17. Ezekowitz MD, Bridgers SL, James KE, and SPINAF Investigators. Interim analysis of VA cooperative study, Stroke Prevention in Non Rheumatic Atrial Fibrillation (SPINAF). Circulation. 190l;84(suppl II):II-450. Abstract.
18. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet. 1993;342: 1255-1262.
19. Kipecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation. N Engl J Med. 1987;317:669-674.
20. Adams GF, Merrett JD, Hutchinson WM, Pollack AM. Cerebral embolism and mitral stenosis: survival with and without anticoagulant therapy. J Neurol Neurosurg Psychiatry. 1974;37:378-383.
21. Cosgriff SW. Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann Intern Med. 1952;35:278-287.
22. Ebert RV. Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial. JAMA. 1973;225:724-729.
23. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ. 1964;1:209-212.
24. Flemming HA, Bailey SM. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J. 1971;47:599-604.
25. Cerebral Embolism Study Group. Cardioembolic stroke, early anticoagulation, and brain hemorrhage. Arch Intern Med. 1987;147: 636-640.
26. Babakian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke. 1989;20:1500-1503.
27. Pessin MS, Estol CJ, La Franchise F, Caplan LR. Safety of anticoagulation after hemorrhagic infarction. Neurology. 1993;43: 1298-1303.
28. Sherman DG, Dyken ML, Fisher M, Antithrombotic therapy for cerebrovascular disorders. Chest. 1989;95(suppl):140-155.
29. Horowitz SH, Zito JL, Donnarumma R, Patel M, Alvir J. Computed tomographic angiographic findings within the first five hours of cerebral infarction. Stroke. 1991;22:1245-1253.
30. Miller VT, Hart RG. Heparin anticoagulation in acute brain ischemia. Curr Concepts Cerebrovasc Dis Stroke. 1987;22:7-11.
31. Haley EC Jr, Kassell NF, Torner JC. Failure of heparin to prevent progression in progressing cerebral ischemic infarction. Stroke. 1988;19:10-14.
32. Phillips SJ. Heparin anticoagulation in focal cerebral ischemia: an alternative view. Stroke. 1989;20:295-298.
33. Marsh EE, Adams HP Jr, Biller J, Wasek P, Banwart K, Mitchell V, Woolson R. Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology. 1989;39:1631-1636.
34. Scheinberg P. Heparin anticoagulation. Stroke. 1989;20:173-174.
35. European Carotid Surgery Trialists Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991;337:1235-1243.
36. Mayberg MR, Wilson SE, Yatsu F, Weiss DG, Messina L, Hershey LA, Colling C, Eskridge J, Deykin D, Winn RH, for the Veterans Affairs Cooperative Studies Program 309 Trialist Group. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA. 1991;266:3289-3294.
37. Alexandrov AV, Bladin CF, Maggisano R, Norris JW. Measuring stenosis: time for a reappraisal. Stroke. 1993;24:1292-1296.
38. Barnett HJM, Warlow CP. Carotid endarterectomy and the measurement of stenosis. Stroke. 1993;24:1281-1284. Editorial.
39. Heros RC, Nelson PB. Intracerebral hemorrhage after micro- surgical cerebral revascularization. Neurosurgery. 1980;6:371-375.
40. Caplan LR, Skillman J, Ojemann R, Fields WS. Intracerebral hemorrhage following carotid endarterectomy: a hypertensive complication. Stroke. 1978;9:457-460.
41. McCormick PW, Spetzler RF, Bailes JE, Zambraski JM, Frey JL. Thromboendarterectomy of the symptomatically occluded internal carotid artery. J Neurosurg. 1992;76:752-758.
42. Meyer FB, Sundt TM Jr, Piepgras DG, Sandok BA, Forbes G. Emergency carotid endarterectomy for patients with acute carotid occlusion and profound neurologic defects. Ann Surg. 1986;203:82-89.
43. Mayo Asymptomatic Carotid Endarterectomy Study Group. Effectiveness of carotid endarterectomy for asymptomatic carotid stenosis: design of a clinical trial. Mayo Clin Proc. 1989;64:897-904.
44. The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke. 1991;22: 1229-1235.
45. Hobson RW II, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, Wright CB, and the Veterans Affairs Cooperative Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med. 1993;328:221-227.
46. The Asymptomatic Carotid Atherosclerosis Study Group. Study design for a randomized prospective trial of carotid endarter ectomy for asymptomatic atherosclerosis. Stroke. 1989;201: 844-849.
47. Barnett HJM, Haines SJ. An editorial: carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med. 1993;328:276-279.
48. Heyman A, Wilkinson WE, Heyden S, Helms MJ, Bartel AG, Karp HR, Tyroler HA, Hames CG. Risk of stroke in asymptomatic persons with cervical arterial bruits: a population study in Evans County, Georgia. N Engl J Med. 1980;302:838-841.
49. Hennerici M, Hulsbomer HB, Herter H, Lammerts D, Rautenberg W. Natural history of asymptomatic extracranial arterial disease: results of a long term prospective study. Brain. 1987;110:777-791.
50. Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. N Engl J Med. 1986;315:860-865.
51. Fisher M, Bogousslavsky J. Evolving toward effective therapy for acute ischemic stroke. JAMA. 1993;270:360-364.
52. Scheinberg P. The biologic basis for the treatment of acute stroke. Neurology. 1991;41:1867-1873.
53. Adams HP Jr. Trials of trials in acute ischemic stroke: the Humana Lecture. Stroke. 1993;24:1410-1415.
54. Barsan WG, Brott TG, Olinger CP, Adams HP Jr, Haley EC Jr, Levy DE. Identification and entry of the patient with acute cerebral infarction. Ann Emerg Med. 1988;17:1192-1195.
55. Ottenbacher KJ, Jannel S. The results of clinical trials in stroke rehabilitation research. Arch Neurol. 1993;50:37-44.